Skip to main content
. 2019 Dec 3;40(2):393–404. doi: 10.1111/liv.14304

Figure 3.

Figure 3

(A) Mortality (considering liver transplantation as a competing risk), as well as (B) liver‐related death and (C) (further) hepatic decompensation (considering liver transplantation and non‐liver‐related death as competing risks) according to 17β‐hydroxysteroid dehydrogenase 13 (HSD17B13) rs72613567 genotype. Abbreviations: 95% CI, 95% confidence interval; aSHR, adjusted subdistribution hazard ratio